Table 2. Bibliographic information on FDA-registered antipsychotic trials.
Sponsor | Drug Name | Trial Number or Identifier | First Author | Year | Journal Name | PubMed ID | Reference |
AstraZeneca | Quetiapine | 0006 | Borison | 1996 | J Clin Psychopharmacol | 8690831 | [35] |
0001/0008 | Small | 1997 | Arch Gen Psychiatry | 9193196 | [57] | ||
0013 | Arvanitis | 1997 | Biol Psychiatry | 9270900 | [58] | ||
BMS | Aripiprazole | 93202 | Unpublished | ||||
94202 | Unpublished | ||||||
97201 | Kane | 2002 | J Clin Psychiatry | 12363115 | [59] | ||
97202 | Potkin | 2003 | Arch Gen Psychiatry | 12860772 | [60] | ||
138001 | McEvoy | 2007 | J Psychiatr Res | 17631314 | [61] | ||
Janssen | Paliperidone | 303 | Kane | 2007 | Schizophr Res | 17092691 | [62] |
304 | Marder | 2007 | Biol Psychiatry | 17601495 | [63] | ||
305 | Davidson | 2007 | Schizophr Res | 17466492 | [64] | ||
Risperidone | 201 | Borison | 1992 | Psychopharmacol Bull | 13811002 | [37] | |
204 (US sites) | Marder | 1994 | Am J Psychiatry | 7514366 | [41] | ||
204 (Canadian sites) | Chouinard | 1993 | J Clin Psychopharmacol | 7683702 | [40] | ||
Risperidone LAI | RIS-USA-121 | Kane | 2003 | Am J Psychiatry | 12777271 | [65] | |
Lilly | Olanzapine | HGAD | Beasley | 1996 | Neuropsychopharmacology | 8822534 | [66] |
HGAP | Beasley | 1996 | Psychopharmacology (Berl) | 8935812 | [67] | ||
Novartis/Vanda | Iloperidone | 3000 | Potkin | 2008 | J Clin Psychopharmacol | 18334911 | [31] |
3004 | |||||||
3005 | |||||||
3101 | Cutler | 2008 | J Clin Psychopharmacol | 18334909 | [34] | ||
Pfizer | Ziprasidone | 104 | Unpublished | ||||
106 | Keck | 1998 | Psychopharmacology (Berl) | 9860108 | [36] | ||
114 | Daniel | 1999 | Neuropsychopharmacology | 10192829 | [68] | ||
115 | Unpublished |